Maximum quantity allowed is 999
请选择数量
CAS RN: 568-72-9 | 產品號碼: T2987
| 產品號碼 | T2987 |
純度/分析方法 
|
>97.0%(HPLC) |
| 分子式 / 分子量 | C__1__9H__1__8O__3 = 294.35 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Refrigerated (0-10°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器
|
10MG-Glass Bottle with Plastic Insert （閲覽圖片）, 50MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 568-72-9 |
| Reaxys-RN | 288781 |
| PubChem Substance ID | 253659875 |
| MDL編號 | MFCD00238692 |
產品規格
| Appearance | Orange to Brown powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Melting point | 197.0 to 202.0 °C |
性質
| 熔點 | 198 °C |
GHS
相關法規
| RTECS # | SF8282695 |
運輸資料
| HS編碼* | 2932.99-000 |
Application
Tanshinone IIA: A Major Lipophilic Component Extracts from the Root of Salvia miltiorrhiza
Tanshinone IIA, a derivative of phenanthrenequinone, is a major lipophilic component extracts from the root of Salvia miltiorrhiza which is widely used Chinese herbal medicine in treating cardiovascular disease. Biological studies suggested that tanshinone IIA shows a variety of pharmacological activities, such as anticancer, anti-inflammatory, and cardio-cerebrovascular protection activities. (The product is for research purpose only.)
References
- Potential anticancer activity of tanshinone IIA against human breast cancer
- Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
- Tanshinone IIA inhibits LPS-induced NF- B activation in RAW 264.7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways
- Cardiovascular actions and therapeutic potential of tanshinone IIA (a review)
- Tanshinone II-A: new perspectives for old remedies (a review)
PubMed Literature
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。